v3.26.1
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Compensation Cost Recognized

Presented below is a summary of the compensation cost recognized in the condensed consolidated statements of operations and comprehensive loss for the three months ended March 31, 2026 and 2025.

 

 

Three Months Ended March 31,

 

(in thousands)

 

2026

 

 

2025

 

Research and development

 

$

55

 

 

$

699

 

Sales and marketing

 

 

-

 

 

 

-

 

General and administrative

 

 

339

 

 

 

1,390

 

Total

 

$

394

 

 

$

2,089

 

Summary of Stock Option Activity

The following summary sets forth the stock option activity under the 2023 and 2020 Plan:

 

 

Number of options

 

 

Weighted average exercise price

 

 

Weighted average remaining contractual term (in years)

 

 

Aggregate intrinsic value (in thousands)

 

Outstanding as of December 31, 2025

 

 

7

 

 

$

100,644

 

 

 

7.3

 

 

$

 

Granted

 

 

 

 

$

 

 

 

 

 

 

 

Exercised

 

 

 

 

$

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

 

 

$

 

 

 

 

 

 

 

Outstanding as of March 31, 2026

 

 

7

 

 

$

100,644

 

 

 

7.3

 

 

$

 

Options exercisable as of March 31, 2026

 

 

4

 

 

$

513,794

 

 

 

7.2

 

 

$

 

Options unvested as of March 31, 2026

 

 

3

 

 

$

1,738,503

 

 

 

7.4

 

 

$